CDK2AP1 antibody (N-Term)
Quick Overview for CDK2AP1 antibody (N-Term) (ABIN602652)
Target
See all CDK2AP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Recognizes human CDK2AP1.
-
Purification
- Protein G purified
-
Immunogen
-
Synthetic peptide corresponding to the N-terminal region of human CDK2AP1.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG1
-
-
-
-
Application Notes
-
Approved: ICC, WB
Usage: Suitable for use in Western Blot and Immunocytochemistry. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 1 % BSA, 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- May be stored at 4°C for short-term only. For long-term storage and to avoid freeze-thaw cycles, add sterile glycerol (40-50%), aliquot and store at -20°C. Aliquots are stable for at least 1 year at -20°C.
-
-
- CDK2AP1 (Cyclin-Dependent Kinase 2 Associated Protein 1 (CDK2AP1))
-
Alternative Name
- DOC-1 / CDK2AP1
-
Background
-
Name/Gene ID: CDK2AP1
Synonyms: CDK2AP1, Doc-1, DORC1, Deleted in oral cancer 1, Deleted in oral cancer-1, p12DOC-1, ST19, CDK2-associated protein 1, CDKAP1, DOC1 -
Gene ID
- 8099
-
UniProt
- O14519
Target
-